CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 82 filers reported holding CYTOMX THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 1.90 and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $295,217 | -44.0% | 241,982 | +0.0% | 0.00% | – |
Q1 2024 | $527,519 | +27.5% | 241,981 | -9.3% | 0.00% | – |
Q4 2023 | $413,596 | +20.2% | 266,836 | 0.0% | 0.00% | – |
Q3 2023 | $344,218 | +528.0% | 266,836 | +737.4% | 0.00% | – |
Q2 2023 | $54,810 | +0.4% | 31,866 | -11.9% | 0.00% | – |
Q1 2023 | $54,590 | -5.6% | 36,152 | 0.0% | 0.00% | – |
Q4 2022 | $57,843 | +11.2% | 36,152 | -0.1% | 0.00% | – |
Q3 2022 | $52,000 | -21.2% | 36,185 | 0.0% | 0.00% | – |
Q2 2022 | $66,000 | -88.4% | 36,185 | -83.0% | 0.00% | – |
Q1 2022 | $567,000 | -38.6% | 212,293 | -0.4% | 0.00% | – |
Q4 2021 | $923,000 | -13.7% | 213,085 | +1.4% | 0.00% | – |
Q3 2021 | $1,069,000 | -13.2% | 210,087 | +8.0% | 0.00% | – |
Q2 2021 | $1,232,000 | -19.2% | 194,496 | -1.4% | 0.00% | – |
Q1 2021 | $1,524,000 | +31.8% | 197,236 | +11.8% | 0.00% | – |
Q4 2020 | $1,156,000 | -4.2% | 176,411 | -2.9% | 0.00% | – |
Q3 2020 | $1,207,000 | -20.0% | 181,618 | +0.3% | 0.00% | – |
Q2 2020 | $1,508,000 | +0.7% | 181,084 | -7.2% | 0.00% | – |
Q1 2020 | $1,498,000 | -4.5% | 195,231 | +3.5% | 0.00% | – |
Q4 2019 | $1,568,000 | +10.0% | 188,647 | -2.3% | 0.00% | – |
Q3 2019 | $1,425,000 | -30.1% | 193,055 | +6.2% | 0.00% | -100.0% |
Q2 2019 | $2,040,000 | +1.7% | 181,762 | -2.5% | 0.00% | 0.0% |
Q1 2019 | $2,005,000 | -28.4% | 186,506 | +0.5% | 0.00% | 0.0% |
Q4 2018 | $2,802,000 | -13.2% | 185,552 | +6.3% | 0.00% | 0.0% |
Q3 2018 | $3,229,000 | -9.0% | 174,545 | +12.4% | 0.00% | 0.0% |
Q2 2018 | $3,549,000 | -7.9% | 155,241 | +14.6% | 0.00% | 0.0% |
Q1 2018 | $3,854,000 | +40.9% | 135,492 | +4.5% | 0.00% | 0.0% |
Q4 2017 | $2,736,000 | +16.6% | 129,637 | +0.4% | 0.00% | 0.0% |
Q3 2017 | $2,347,000 | +30.8% | 129,182 | +11.6% | 0.00% | 0.0% |
Q2 2017 | $1,794,000 | +20.2% | 115,777 | +33.9% | 0.00% | – |
Q1 2017 | $1,493,000 | +56.3% | 86,458 | -0.5% | 0.00% | – |
Q4 2016 | $955,000 | -27.7% | 86,863 | +3.2% | 0.00% | – |
Q3 2016 | $1,320,000 | +80.1% | 84,165 | +17.3% | 0.00% | – |
Q2 2016 | $733,000 | +144.3% | 71,738 | +208.4% | 0.00% | – |
Q1 2016 | $300,000 | -21.5% | 23,264 | +27.2% | 0.00% | – |
Q4 2015 | $382,000 | – | 18,285 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 3,559,722 | $23,672,000 | 1.29% |
Congress Park Capital LLC | 78,561 | $522,000 | 0.32% |
Exane Asset Management | 63,820 | $424,403,000 | 0.28% |
Perceptive Advisors | 2,577,043 | $17,137,000 | 0.25% |
RTW INVESTMENTS, LP | 1,526,003 | $10,148,000 | 0.24% |
Jackson Creek Investment Advisors LLC | 80,504 | $535,000 | 0.24% |
HARBOURVEST PARTNERS LLC | 79,193 | $527,000 | 0.20% |
TANG CAPITAL MANAGEMENT LLC | 112,880 | $751,000 | 0.14% |
Virtus ETF Advisers LLC | 38,721 | $257,000 | 0.14% |
GLOBEFLEX CAPITAL L P | 69,435 | $462,000 | 0.12% |